MEDI5752 in Japanese Patients With Advanced Solid Tumors.

NCT05685472 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca